Patents by Inventor Harry B. Larman

Harry B. Larman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240401156
    Abstract: The present invention relates to the field of ribonucleic acid (RNA). More specifically, the present invention provides compositions and methods for highly multiplexed detection of pathogen-associated RNA. In a specific embodiment, a method for forming a target ribonucleic acid (RNA) proxy in a sample comprises the steps of (a) contacting a sample with one or more multi-partite probes that hybridize to a target RNA, wherein the one or more multi-partite probes comprise (i) a target capture probe, (ii) a 3?acceptor probe and (iii) a 5? phosphorylated donor probe; (b) incubating the sample of step (a) under conditions that allow hybridization of the one or more multi-partite probes to target RNA present in the sample; (c) immobilizing the target capture probes on a solid support; (d) washing away unbound multi-partite probes; and € ligating the acceptor probes and donor probes to form a target RNA proxy.
    Type: Application
    Filed: October 8, 2020
    Publication date: December 5, 2024
    Inventors: Harry B. Larman, Joel Credle
  • Patent number: 12091776
    Abstract: The present invention relates to the field of proteases. More specifically, the present invention provides compositions and methods useful for profiling protease activity using phage display. In one embodiment, a display vector useful for profiling protease activity comprises a nucleic acid sequence encoding (a) a peptide to be displayed on the surface of the vector; (b) a first affinity tag C-terminal to the peptide; and (c) a second affinity tag N-terminal to the peptide. The display vector can comprise a virus, bacteriophage, yeast, bacteria, retrovirus, ribosome or mRNA. In particular embodiments, the peptide comprises a human peptidome library peptide.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: September 17, 2024
    Assignee: The John Hopkins University
    Inventors: Harry B. Larman, Gabriel Roman-Melendez, Thiagarajan Venkataraman
  • Patent number: 11821110
    Abstract: Provided herein are methods of detecting an antibody directed against a pathogen and uses thereof.
    Type: Grant
    Filed: July 8, 2020
    Date of Patent: November 21, 2023
    Assignees: The Brigham and Women's Hospital, Inc., President and Fellows of Harvard College
    Inventors: Stephen J. Elledge, Harry B. Larman, Tomasz Kula, George Xu
  • Publication number: 20230251269
    Abstract: The present invention relates to the field of allergies. More specifically, the present invention provides compositions and methods useful for identifying anti-allergen antibodies in a patient sample using phage display. In one embodiment, a method for detecting the presence of an antibody against an allergen in subject includes the steps of (a) contacting a reaction sample comprising a display library with a biological sample comprising antibodies, wherein the display library includes a plurality of peptides derived from a plurality of allergens; and (b) detecting at least one antibody bound to at least one peptide expressed by the display library, thereby detecting an antibody against the at least one peptide in the biological sample.
    Type: Application
    Filed: July 15, 2021
    Publication date: August 10, 2023
    Inventors: Harry B. Larman, Daniel Monaco
  • Publication number: 20220251541
    Abstract: Provided herein are methods of detecting an antibody directed against a pathogen and uses thereof.
    Type: Application
    Filed: January 25, 2022
    Publication date: August 11, 2022
    Applicants: The Brigham and Women's Hospital, Inc., President and Fellows of Harvard College
    Inventors: Stephen J. ELLEDGE, Harry B. LARMAN, Tomasz KULA, George XU
  • Publication number: 20220065857
    Abstract: Described are methods for estimating the cross-sectional incidence or duration of infection of a virus. Method steps include obtaining a biological sample with antibodies from a subject having a viral infection. The biological sample is mixed with two or more epitopes or peptides from the proteins of a vims responsible for the viral infection. The amount of antibody binding to the epitopes or peptides is quantified and the cross-sectional incidence or duration of infection of a virus is estimated.
    Type: Application
    Filed: December 9, 2019
    Publication date: March 3, 2022
    Inventors: Susan H. Eshleman, Oliver Laeyendecker, Harry B. Larman, Kai Kammers
  • Publication number: 20200407467
    Abstract: The present invention relates to the field of proteases. More specifically, the present invention provides compositions and methods useful for profiling protease activity using phage display. In one embodiment, a display vector useful for profiling protease activity comprises a nucleic acid sequence encoding (a) a peptide to be displayed on the surface of the vector; (b) a first affinity tag C-terminal to the peptide; and (c) a second affinity tag N-terminal to the peptide. The display vector can comprise a virus, bacteriophage, yeast, bacteria, retrovirus, ribosome or mRNA. In particular embodiments, the peptide comprises a human peptidome library peptide.
    Type: Application
    Filed: June 26, 2020
    Publication date: December 31, 2020
    Inventors: Harry B. Larman, Gabriel Roman-Melendez, Thiagarajan Venkataraman
  • Publication number: 20200333356
    Abstract: Provided herein are methods of detecting an antibody directed against a pathogen and uses thereof.
    Type: Application
    Filed: July 8, 2020
    Publication date: October 22, 2020
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Stephen J. Elledge, Harry B. Larman, Tomasz Kula, George Xu
  • Patent number: 10768181
    Abstract: Provided herein are methods of detecting an antibody directed against a pathogen and uses thereof. One aspect provided herein relates to a method for detecting an antibody against a pathogen in a subject, the method comprising: (a) contacting a reaction sample comprising a display library with a biological sample comprising antibodies, wherein the display library comprises a plurality of peptides derived from a plurality of pathogens, and (b) detecting a peptide bound to at least one antibody, thereby detecting an antibody capable of binding the peptide.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: September 8, 2020
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Stephen J. Elledge, Harry B. Larman, Tomasz Kula, George Xu
  • Publication number: 20190055545
    Abstract: Provided herein are methods of detecting an antibody directed against a pathogen and uses thereof.
    Type: Application
    Filed: January 27, 2017
    Publication date: February 21, 2019
    Applicants: The Brigham and Women's Hospital, Inc., President and Fellows of Harvard College
    Inventors: Stephen J. ELLEDGE, Harry B. LARMAN, Tomasz KULA, George XU
  • Publication number: 20160320406
    Abstract: Provided herein are methods of detecting an antibody directed against a pathogen and uses thereof. One aspect provided herein relates to a method for detecting an antibody against a pathogen in a subject, the method comprising: (a) contacting a reaction sample comprising a display library with a biological sample comprising antibodies, wherein the display library comprises a plurality of peptides derived from a plurality of pathogens, and (b) detecting a peptide bound to at least one antibody, thereby detecting an antibody capable of binding the peptide.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 3, 2016
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Stephen J. Elledge, Harry B. Larman, Tomasz Kula, George Xu
  • Publication number: 20090209436
    Abstract: A method for fabricating hydrogel based microarrays by a nanostamping process is provided. A method of manufacturing a patterned hydrogel array is provided comprising the steps of contacting a patterned substrate with a hydrogel substrate to form a substrate complex, wherein the patterned substrate comprises a surface, a first polymer attached to the surface, and a second polymer reversibly attached to the first polymer, the hydrogel substrate comprises a polymer matrix and a plurality of attachment sites along the polymer matrix capable of attaching the second polymer, binding at least one attachment site to the second polymer, disassociating the dimer; and separating the substrate complex to obtain a patterned hydrogel array having a second polymer attached to an attachment site. Methods where the second polymer is synthesized using the first polymer as template are provided. Hydrogel arrays manufactured according to the methods of the invention are provided.
    Type: Application
    Filed: September 17, 2008
    Publication date: August 20, 2009
    Applicant: TWOF, Inc.
    Inventors: Harry B. Larman, Andrea Cuppoletti